Radiosensitizing Effect of Antitumor Enediyne Prodrugs Possessing DNA-Cleaving Activity under Hypoxic Conditions

低氧条件下具有 DNA 切割活性的抗肿瘤烯二炔前药的放射增敏作用

基本信息

  • 批准号:
    12557075
  • 负责人:
  • 金额:
    $ 2.43万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2002
  • 项目状态:
    已结题

项目摘要

DNA-Cleaving activity and applicability to radiation therapy of hypoxic-tumor cells are evaluated for three classes of compounds: (A) 10-membered 1,5-diyne compounds that are rearranged to unstable enediyne structures by bioactivation, (B) propargylic sulfones that are base-induced isomerized to activated allenic forms, (C) propargylic sulfones with electron-affinic nitroazole structures possessing hypoxic-cell sensitizing activity. The following conclusions were obtained.(1) 10-Membered 1,5-diyne compounds are confirmed to be prodrugs showing DNA-cleaving activity under acidic conditions that are characteristic of hypoxic cells. The compounds with leaving ester groups were 10 times more active than the analogues with hydroxyl group or methoxy group.(2) While 10-membered 1,5-diyne compounds with phenyl group and 2-naphtyl group, respectively, have almost equivalent DNA-intercalating ability, the latter showed higher DNA-cleaving activity. This indicates that the DNA cleavage may be str … More ongly influenced by the spatial arrangement upon intercalation into DNA double strand.(3) Propargylic sulfones bearing 2-nitroimidazole structures were confirmed to be prodrugs that showed hypoxic selective cytotoxicity towards EMT6/KU cells. The DNA-cleaving activity, glutathione-capturing reactivity, cell permeability, and radiosensitizing activity of these novel propargylic sulfones were evaluated.(4) Propargylic sulfones bearing various substituents were synthesized to evaluate rate of the isomerization to activated allenic forms, DNA-cleaving activity, and cytotoxicity towards mouse tumor cells, thus elucidating activation mechanism of the prodrugs.(5) Upon introduction of electron withdrawing nitro group the propargylic sulfone compounds have higher glutathione capturing reactivity but less hydrophilic property. This was improved by introduction of additional hydrophilic groups, by which the propargylic sulfone compounds recovered solubility in water with maintaining relatively high glutathione-capturing reactivity. Less
评价了三类化合物的DNA裂解活性和对缺氧肿瘤细胞的放射治疗的适用性:(A)通过生物活化重排为不稳定的烯二炔结构的10元1,5-二炔化合物,(B)碱诱导异构化为活化的丙二烯形式的炔丙基砜,(C)具有亲电子硝基唑结构的炔丙基砜,其具有缺氧细胞敏化活性。得出以下结论。(1)10元1,5-二炔化合物被证实是在缺氧细胞特有的酸性条件下显示DNA切割活性的前药。具有离去酯基的化合物比具有羟基或甲氧基的类似物的活性高10倍。(2)含苯基和2-萘基的10元1,5-二炔类化合物的DNA嵌入能力基本相当,而2-萘基的10元1,5-二炔类化合物的DNA切割活性较高。这表明DNA断裂可能是强的, ...更多信息 仅受嵌入DNA双链时的空间排列的影响。(3)具有2-硝基咪唑结构的炔丙砜被证实是对EMT 6/KU细胞表现出缺氧选择性细胞毒性的前药。对这些新型炔丙基砜的DNA切割活性、谷胱甘肽捕获反应性、细胞渗透性和放射增敏活性进行了评价。(4)合成了具有不同取代基的炔丙基砜,以评价异构化为活化的丙二烯形式的速率、DNA切割活性和对小鼠肿瘤细胞的细胞毒性,从而阐明前药的活化机制。(5)引入吸电子硝基后,炔丙基砜类化合物具有更高的谷胱甘肽捕获活性,但亲水性较差。这通过引入额外的亲水基团得到改善,通过该亲水基团,炔丙基砜化合物恢复了在水中的溶解度,同时保持相对高的谷胱甘肽捕获反应性。少

项目成果

期刊论文数量(58)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
芝本雄太: "A Phase Ia Study of a Hypoxic Cell Sensitizer Doranidazole in Combination with Conventional Radiotherapy"Anti-Cancer Drugs. 12・. 1-6 (2001)
Yuta Shibamoto:“缺氧细胞敏化剂多拉硝唑与常规放射治疗相结合的 Ia 期研究”抗癌药物 12・。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
西本清一: "N(1)-C(5)-Linked Dimer Hydrates of 5-Substituted Uracils Produced by Electrolytic Oxidation in Aqueous Solution"Journal of Organic Chemistry. 66・7. 2232-2239 (2001)
Seiichi Nishimoto:“水溶液中电解氧化产生的 5-取代尿嘧啶的 N(1)-C(5)-连接二聚体水合物”有机化学杂志 66・7 (2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
西本清一: "Interaction of Amyloid β-Protein with Various Gangliosides in Raft-Like Membrane : Importance of GM1 Ganglioside-Bound Form as an Endogeneous Seed for Altzheimer"Biochemistry. 41. 7385-7390 (2002)
Seiichi Nishimoto:“淀粉样 β-蛋白与筏状膜中各种神经节苷脂的相互作用:GM1 神经节苷脂结合形式作为阿尔茨海默氏症内源性种子的重要性”生物化学 41. 7385-7390 (2002)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
西本清一: "DNA Cleaving Potency, Cytotoxicity, and Mechanism of Action of a Novel Class of Endiyne Prodrugs"Journal of Medicinal Chemistry. 45・4. 758-761 (2002)
Seiichi Nishimoto:“新型 Endiyne 前药的 DNA 裂解效力、细胞毒性和作用机制”《药物化学杂志》45・4(2002 年)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Dai, W.-M, Wu, A., Hamaguchi, W., Lee, M. Y. H., Zhou, L., Atsushi Ishii, Nishimoto, S.: "DNA Cleaving Potency, Cytotoxicity, and Mechanism of Action of a Novel Class of Endiyne Prodrugs"Journal of Medicinal Chemistry. 45. 758-761 (2002)
Dai, W.-M, Wu, A., Hamaguchi, W., Lee, M. Y. H., Zhou, L., Atsushi Ishii, Nishimoto, S.:“一类新型药物的 DNA 切割效力、细胞毒性和作用机制
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NISHIMOTO Sei-ichi其他文献

NISHIMOTO Sei-ichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NISHIMOTO Sei-ichi', 18)}}的其他基金

Redox Splitting Mechanism of C(5)-C(5)-linked Dihydrothymine Dimers
C(5)-C(5)-连接的二氢胸腺嘧啶二聚体的氧化还原裂解机制
  • 批准号:
    09640632
  • 财政年份:
    1997
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Radiolytic Reduction Activating Prodrugs Possessing 5-Fluorouracil-Releasing Ability : Radiation Sensitizing Effect on Mouse Tumors
具有5-氟尿嘧啶释放能力的放射解还原激活前药:对小鼠肿瘤的放射增敏作用
  • 批准号:
    09557069
  • 财政年份:
    1997
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Synthesis and SQAR of DNA-Cleaving Propargylic Sulfones
DNA 切割炔丙砜的合成和 SQAR
  • 批准号:
    08044141
  • 财政年份:
    1996
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Development of Photocatalytic Organic Synthesis Processes of Next Generation
下一代光催化有机合成工艺的发展
  • 批准号:
    07555574
  • 财政年份:
    1995
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Activation Mechanism of Prodrugs Releasing 5-Fluorouracil by Radiolytic Reduction
放射还原释放5-氟尿嘧啶前药的激活机制
  • 批准号:
    07455339
  • 财政年份:
    1995
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Correlation between morphology and radiation resistance of polypropylene materials
聚丙烯材料形貌与耐辐射性能的相关性
  • 批准号:
    62550651
  • 财政年份:
    1987
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了